MENU
ROIV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Roivant Sciences (ROIV) Ownership - Who owns Roivant Sciences?
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more
Profile
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.15B
P/E Ratio
1.97
Total Cash
4.5B
Projected Growth
N/A
Total Debt
99.69M
Revenue
23.23M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
6.59
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
ROIV
Capitalization
8.15B
P/E Ratio
1.97
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
4.5B
Total Cash/Share
6.59
Total Debt
99.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
23.2M
ROE
N/A
Book Value
4.35B
P/B Ratio
1.87
Cash Flow
N/A
Earnings
-0.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
40.54
Current Revenue Per Employee
2893.33
Dividends Per Share - Security
N/A
EBITDA
-1.18B
Float
N/A
Float - Current
N/A
Gross Income Margin
92.90
Revenue To Assets
-8.51
Shares Held By Institutions
9.98B
Shares Outstanding - Current
683M
Total Liabilities
217M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.845
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ROIV showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A